Ptc Therapeutics Cash Flow Statement (2012-2025) | PTCT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-128.64M	-118.37M	-133.62M	344.46M	-126.73M	-152.09M	-109.31M	-203.58M	-138.96M	-198.88M	-132.97M	628.95M	-91.58M	-99.18M	-106.65M	-92.51M	866.56M	-64.85M	15.90M	-1373.54M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)	25.71M	25.70M	25.87M	26.24M	26.59M	27.73M	28.67M	27.34M	28.82M	29.37M	26.94M		18.38M	19.24M	19.75M	17.24M	18.06M	18.54M	19.43M	18.52M
Deferred Taxes (Quarter)									-0.00M	-50.90M	-0.00M	3.98M	-0.00M	0.00M	-0.00M	-55.91M	0.00M			0.00M
Gains from Sales and Divestitures (Quarter)	0.30M	0.32M	0.33M	0.34M	0.43M	0.48M	0.49M	0.50M	0.70M	0.75M	0.78M	0.92M	0.84M	0.89M	0.92M	0.96M	1.09M	1.13M	1.20M	0.09M
Gains from Investment Securities (Quarter)	0.01M	2.28M	0.86M		0.59M	0.04M		-30.37M		0.08M	11.44M	14.29M	2.04M	-4.20M	0.93M	-10.26M	3.04M	1.85M	-0.10M	0.70M
Asset Writedowns and Impairment (Quarter)										217.80M				0.20M	1.30M	159.50M		0.10M	0.40M	0.50M
Non-cash Items (Quarter)	4.75M	5.26M	5.59M	50.56M	38.08M	7.21M	111.77M	38.33M	8.35M	8.26M	5.08M	7.65M	12.03M	7.18M	7.25M	6.84M	6.51M	6.46M	6.13M	210.69M
Cash from Operations (Quarter)	-100.16M	-31.14M	-51.19M	-68.84M	-97.40M	-55.24M	-38.05M	-165.96M	-29.49M	-14.12M	-14.52M	-100.29M	70.76M	-71.45M	-76.99M	-30.00M	870.10M	-58.33M	-66.30M	-34.27M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-1.36M	-1.28M	-1.41M	11.44M	-0.89M	-0.65M	-0.25M	11.68M	0.09M	5.59M	-5.58M	2.11M	3.70M	3.30M	2.95M	-2.19M	2.31M	1.32M	2.00M	12.39M
Amortization of Deferred Charges (Quarter)	0.45M	0.28M	0.18M	0.47M	0.46M	0.28M	0.29M	0.58M	0.44M	0.29M	0.28M	0.30M	0.30M	0.29M	0.30M	0.31M	0.30M	0.30M	0.31M	0.31M
Depreciation & Amortization (CF) (Quarter)	13.59M	14.99M	16.75M	18.81M	26.31M	29.18M	34.48M	38.87M	42.83M	51.01M	62.05M	80.70M	55.40M	7.02M	6.49M	6.76M	7.22M	7.58M	11.11M	12.90M
Change in Working Capital
Change in Receivables (Quarter)	25.01M	-15.59M	19.20M	16.37M	28.37M	1.18M	-4.78M	23.70M	43.43M	-25.40M	-8.13M	-8.35M	39.50M	-8.19M	7.72M	-40.76M	47.79M	-21.90M	6.47M	-22.21M
Change in Inventory (Quarter)	-1.96M	0.06M	-0.57M	0.68M	-0.35M	0.32M	0.80M	5.90M	4.61M	5.18M	4.33M	-5.94M	-0.12M	1.94M	3.11M	-11.09M	-2.19M	10.78M	18.53M	26.78M
Change in Accured Expenses (Quarter)	-28.76M	25.67M	-1.26M	-2.36M	-3.09M	-1.08M	3.26M	-3.65M	-3.99M	0.93M	43.49M	-42.74M	-5.39M	-13.31M	13.97M	16.56M	18.50M	-35.82M	-19.02M	18.95M
Other Working Capital Changes (Quarter)	-15.61M	-0.04M	7.49M	23.47M	-25.12M	8.69M	52.05M	16.01M	-57.61M	-6.34M	4.48M	104.46M	-93.90M	-5.89M	-8.17M	9.19M	7.20M	5.00M	1.68M	22.94M
Investing Activities
Capital Expenditures (Quarter)	5.67M	7.97M	5.84M	8.73M	9.31M	8.70M	5.38M	8.62M	0.03M	16.49M	6.36M	5.57M	9.59M	-7.38M	0.52M	-2.67M	1.72M	1.32M	3.44M	2.37M
Sales of Property, Plant and Equipment (Quarter)															0.02M		0.07M
Change in Intangibles (Quarter)	14.19M	7.65M	19.97M	15.31M	72.13M	9.29M	20.64M	18.38M	33.40M	13.04M	22.85M	22.90M	54.76M		10.25M	2.73M	0.81M	2.68M	252.75M	34.92M
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)	392.09M		0.70M	450.70M	167.10M	1.20M	100.80M	-229.03M	12.50M	2.21M	7.83M	110.68M	61.65M	19.37M	21.05M	-242.71M	136.75M	8.23M	22.98M	743.78M
Cash from Investing Activities (Quarter)	30.15M	56.06M	64.70M	68.27M	49.04M	72.25M	136.44M	32.44M	-28.97M	-23.75M	-29.60M	-94.42M	-114.93M	-65.92M	-42.67M	267.71M	-184.36M	-422.01M	-289.62M	34.01M
Financing Activities
Other financing activities (Quarter)									0.18M	0.01M	0.09M
Cash from Financing Activities (Quarter)	9.53M	4.02M	2.98M	4.35M	1.17M	3.86M	-140.00M	302.92M	4.09M	18.46M	3.36M	620.49M	0.54M	246.48M	-17.63M	26.47M	9.41M	3.96M	15.22M	302.50M
Additional items
Exchange Rate Effect (Quarter)	-1.70M	1.79M	-4.02M	-3.89M	1.65M	1.69M	-12.14M	6.02M	-7.96M	10.31M	-2.33M	3.10M	-2.03M	-5.19M	8.54M	-8.65M	5.39M	13.59M	-6.06M	9.79M
Change in Cash (Quarter)	-62.18M	30.71M	12.47M	-0.10M	-45.54M	22.57M	-53.73M	175.41M	-62.33M	-9.10M	-43.09M	428.87M	-45.66M	103.92M	-128.75M	255.53M	700.55M	-462.79M	-346.77M	312.03M
Free Cash Flow (Quarter)	-105.83M	-39.12M	-57.03M	-77.57M	-106.72M	-63.94M	-43.43M	-174.59M	-29.52M	-30.61M	-20.88M	-105.85M	61.17M	-64.08M	-77.51M	-27.34M	868.38M	-59.65M	-69.75M	-36.65M
Net Cash Flow (Quarter)	-60.48M	28.93M	16.49M	3.79M	-47.19M	20.87M	-41.59M	169.39M	-54.37M	-19.41M	-40.75M	425.78M	-43.63M	109.11M	-137.29M	264.18M	695.15M	-476.38M	-340.70M	302.24M

Research Tools

Ptc Therapeutics Cash Flow Statement (2012-2025) | PTCT

Create an account

Sign In

Reset Password